(NASDAQ: CRBU) Caribou Biosciences's forecast annual revenue growth rate of 91% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 78.36%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Caribou Biosciences's revenue in 2025 is $6,768,000.On average, 4 Wall Street analysts forecast CRBU's revenue for 2025 to be $826,189,376, with the lowest CRBU revenue forecast at $465,616,195, and the highest CRBU revenue forecast at $976,862,777. On average, 3 Wall Street analysts forecast CRBU's revenue for 2026 to be $3,748,489,739, with the lowest CRBU revenue forecast at $931,232,390, and the highest CRBU revenue forecast at $9,312,323,900.
In 2027, CRBU is forecast to generate $3,911,734,777 in revenue, with the lowest revenue forecast at $1,026,218,094 and the highest revenue forecast at $9,312,323,900.